We determin-ed that the sole expression of PAX3-FOXO1 is sufficient to promote aneuploidy and overcome aneuploidy-dependent cell cycle arrest in the progression to the oncogenic state, thereby serving as a driver mutation in ARMS. This evidence concerns the gene FOXO1 and alveolar rhabdomyosarcoma.